Literature DB >> 27984411

Multiple-Drug Resistance in Burn Patients: A Retrospective Study on the Impact of Antibiotic Resistance on Survival and Length of Stay.

Ilse van Langeveld1, Robin C Gagnon, Peggie F Conrad, Richard L Gamelli, Brendan Martin, Mashkoor A Choudhry, Michael J Mosier.   

Abstract

Despite improvements in early treatment, survival following burn injury remains challenged by sepsis and multiple organ dysfunction syndrome (MODS). Additionally, susceptibility to infections and growing antibiotic resistance places burn patients at increased risk for infections with multiple-drug resistant organisms (MDROs). We therefore aimed to evaluate the impact of MDRO infections on survival and hospital length of stay, as well as examine the role of these organisms in the development of complications, such as acute kidney injury, sepsis, and MODS. To study this, we included all burn patients with infections, admitted between January 1, 2012, and December 31, 2013. Patients were divided into two groups: patients with infections caused by MDROs and patients with infections caused by susceptible organisms. Data were collected on all available cultures, as well as demographic, injury, and treatment-related variables from the medical record. The number of operative procedures (median: 2 vs 1, P < .0001), ventilator days (21 vs 0 days, P < .0001), total antibiotic days (21 vs 7days, P < .0001), and length of hospitalization (39 vs 14 days, P < .0001) were significantly different in the MDRO group vs the nonresistant group. While MDRO infection was not associated with patient mortality, univariable logistic regression analyses demonstrated >20% TBSA (odds ratio [OR] = 4.30, 95% confidence interval [CI]: 1.14-16.29, P = .03), acute kidney injury (OR = 10.93, 95% CI: 2.74-43.57, P = .001), sepsis (OR = 19.20, 95% CI: 3.79-97.27, P < .001), and MODS (OR = 85.49, 95% CI: 12.97-563.28, P < .0001) significantly increased the odds of patient mortality. These findings suggest that infections with MDROs are associated with a greater number of surgical procedures, longer duration of mechanical ventilation, more antibiotic days, and longer hospitalization.

Entities:  

Mesh:

Year:  2017        PMID: 27984411      PMCID: PMC5527554          DOI: 10.1097/BCR.0000000000000479

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  32 in total

Review 1.  Support of the metabolic response to burn injury.

Authors:  David N Herndon; Ronald G Tompkins
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

2.  Factors affecting survival in adult patients with massive burns.

Authors:  Yu Wang; Hong-Tai Tang; Zhao-Fan Xia; Shi-Hui Zhu; Bing Ma; Wei Wei; Yu Sun; Kai-Yang Lv
Journal:  Burns       Date:  2009-05-31       Impact factor: 2.744

3.  Morbidity and mortality of bloodstream infections in patients with severe burn injury.

Authors:  Nele Brusselaers; Stan Monstrey; Thomas Snoeij; Dominique Vandijck; Christelle Lizy; Eric Hoste; Stefaan Lauwaert; Kirsten Colpaert; Linos Vandekerckhove; Dirk Vogelaers; Stijn Blot
Journal:  Am J Crit Care       Date:  2010-11       Impact factor: 2.228

4.  Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.

Authors:  Diane M Gomes; Carmen Smotherman; Amy Birch; Lori Dupree; Bethany J Della Vecchia; Dale F Kraemer; Christopher A Jankowski
Journal:  Pharmacotherapy       Date:  2014-04-18       Impact factor: 4.705

5.  Early excision and grafting versus delayed excision and grafting of deep thermal burns up to 40% total body surface area: a comparison of outcome.

Authors:  M Saaiq; S Zaib; S Ahmad
Journal:  Ann Burns Fire Disasters       Date:  2012-09-30

6.  A retrospective analysis of 1083 Turkish patients with serious burns. Part 2: burn care, survival and mortality.

Authors:  R Anlatici; O R Ozerdem; C Dalay; E Kesiktaş; S Acartürk; G Seydaoğlu
Journal:  Burns       Date:  2002-05       Impact factor: 2.744

Review 7.  Acute kidney injury and multiple organ dysfunction syndrome.

Authors:  S Faubel
Journal:  Minerva Urol Nefrol       Date:  2009-09       Impact factor: 3.720

8.  Duration of antibiotic therapy for critically ill patients with bloodstream infections: A retrospective cohort study.

Authors:  Thomas C Havey; Robert A Fowler; Ruxandra Pinto; Marion Elligsen; Nick Daneman
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

9.  Infections in a burn intensive care unit: experience of seven years.

Authors:  S G Santucci; S Gobara; C R Santos; C Fontana; A S Levin
Journal:  J Hosp Infect       Date:  2003-01       Impact factor: 3.926

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  18 in total

Review 1.  Management and prevention of drug resistant infections in burn patients.

Authors:  Roohi Vinaik; Dalia Barayan; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Expert Rev Anti Infect Ther       Date:  2019-08-04       Impact factor: 5.091

2.  Infection control in german-speaking burn centres: results of an online survey.

Authors:  C Baier; R Ipaktchi; E Ebadi; H-O Rennekampff; H-M Just; P M Vogt; F-C Bange; K Suchodolski
Journal:  Ann Burns Fire Disasters       Date:  2018-09-30

3.  A retrospective surveillance of the prophylactic antibiotics for debridement surgery in burn patients.

Authors:  Oki Nugraha Putra; Iswinarno Doso Saputro; Affan Yuniar Nur Hidayatullah
Journal:  Int J Burns Trauma       Date:  2021-04-15

4.  Colonization with Multidrug-Resistant Enterobacteriaceae is Associated with Increased Mortality Following Burn Injury in Sub-Saharan Africa.

Authors:  Jared R Gallaher; Wone Banda; Anne M Lachiewicz; Robert Krysiak; Bruce A Cairns; Anthony G Charles
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

Review 5.  The use of hydrogen peroxide in the treatment of burn wound infection: a systematic review, and survey of current clinical practice in the United Kingdom.

Authors:  Toni Huw Mihailidis
Journal:  Int J Burns Trauma       Date:  2020-04-15

6.  Mortality incidence among critically ill burn patients infected with multidrug-resistant organisms: A retrospective cohort study.

Authors:  Moustafa Ellithy; Hassan Mitwally; Mohamed Saad; Ranjan Mathias; Adila Shaukat; Hani Elzeer; Sunil Hassan Koya; Zia Mahmood; Khaled Gazwi
Journal:  Scars Burn Heal       Date:  2021-05-25

7.  PaP1, a Broad-Spectrum Lysin-Derived Cationic Peptide to Treat Polymicrobial Skin Infections.

Authors:  Ryan D Heselpoth; Chad W Euler; Vincent A Fischetti
Journal:  Front Microbiol       Date:  2022-03-10       Impact factor: 5.640

Review 8.  The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm Pseudomonas aeruginosa in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections.

Authors:  Daniel J Hassett; Rhett A Kovall; Michael J Schurr; Nalinikanth Kotagiri; Harshita Kumari; Latha Satish
Journal:  Front Microbiol       Date:  2021-06-17       Impact factor: 5.640

9.  Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study.

Authors:  Yangmin Hu; Danyang Li; Lingcheng Xu; Yuping Hu; Yiwen Sang; Gensheng Zhang; Haibin Dai
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-30       Impact factor: 4.887

10.  High Level of Multidrug-Resistant Gram-Negative Pathogens Causing Burn Wound Infections in Hospitalized Children in Dar es Salaam, Tanzania.

Authors:  Fatima Kabanangi; Agricola Joachim; Emmanuel James Nkuwi; Joel Manyahi; Sabrina Moyo; Mtebe Majigo
Journal:  Int J Microbiol       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.